Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiago Azenha Rama

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Acta Medica Portuguesa|April 4, 2022
Anisakis Allergy: Raising AwarenessTiago Azenha Rama, Diana Silva
The Journal of Allergy and Clinical Immunology|January 24, 2021
mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxisTiago Azenha Rama, André Moreira, Mariana Castells
Acta Medica Portuguesa|July 17, 2020
[Cutaneous Manifestations in Pediatric Mastocytosis]Tiago Azenha Rama, André Moreira, Luís Delgado
Allergy|December 26, 2022
Real-world evidence on the risk of cancer with anti-IL-5 and anti-IL-4Ra biologicalsDiogo Mota, Tiago Azenha Rama, André Moreira
The Journal of Allergy and Clinical Immunology. in Practice|March 15, 2021
Biphasic Blue UrticariaTiago Azenha Rama, Diana Silva, Josefina Cernadas
Allergy|July 16, 2021
Potential cancer risk with omalizumab? A disproportionality analysis of the WHO's VigiBase pharmacovigilance databaseDiogo Mota, Tiago Azenha Rama, Milton Severo, et al.
Life (Basel, Switzerland)|June 24, 2022
Supply of Antioxidants vs. Recruit Firefighters' Cellular Immune Status: A Randomized Double-Blinded Placebo-Controlled Parallel-Group TrialJosé Augusto Rodrigues Santos, Tiago Azenha Rama, Domingos José Lopes da Silva, et al.
Frontiers in Immunology|March 1, 2021
Case Report: Mastocytosis: The Long Road to DiagnosisTiago Azenha Rama, Diana Martins, Nuno Gomes, et al.
Vaccines|May 28, 2022
COVID-19 Vaccination Is Safe among Mast Cell Disorder Patients, under Adequate PremedicationTiago Azenha Rama, Joana Miranda, Diana Silva, et al.
Frontiers in Microbiology|July 13, 2023
The oral bacteriomes of patients with allergic rhinitis and asthma differ from that of healthy controlsMarcos Pérez-Losada, Eduardo Castro-Nallar, José Laerte Boechat, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Acta Medica Portuguesa|April 4, 2022
Anisakis Allergy: Raising AwarenessTiago Azenha Rama, Diana Silva
The Journal of Allergy and Clinical Immunology|January 24, 2021
mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxisTiago Azenha Rama, André Moreira, Mariana Castells
Acta Medica Portuguesa|July 17, 2020
[Cutaneous Manifestations in Pediatric Mastocytosis]Tiago Azenha Rama, André Moreira, Luís Delgado
Allergy|December 26, 2022
Real-world evidence on the risk of cancer with anti-IL-5 and anti-IL-4Ra biologicalsDiogo Mota, Tiago Azenha Rama, André Moreira
The Journal of Allergy and Clinical Immunology. in Practice|March 15, 2021
Biphasic Blue UrticariaTiago Azenha Rama, Diana Silva, Josefina Cernadas
Allergy|July 16, 2021
Potential cancer risk with omalizumab? A disproportionality analysis of the WHO's VigiBase pharmacovigilance databaseDiogo Mota, Tiago Azenha Rama, Milton Severo, et al.
Life (Basel, Switzerland)|June 24, 2022
Supply of Antioxidants vs. Recruit Firefighters' Cellular Immune Status: A Randomized Double-Blinded Placebo-Controlled Parallel-Group TrialJosé Augusto Rodrigues Santos, Tiago Azenha Rama, Domingos José Lopes da Silva, et al.
Frontiers in Immunology|March 1, 2021
Case Report: Mastocytosis: The Long Road to DiagnosisTiago Azenha Rama, Diana Martins, Nuno Gomes, et al.
Vaccines|May 28, 2022
COVID-19 Vaccination Is Safe among Mast Cell Disorder Patients, under Adequate PremedicationTiago Azenha Rama, Joana Miranda, Diana Silva, et al.
Frontiers in Microbiology|July 13, 2023
The oral bacteriomes of patients with allergic rhinitis and asthma differ from that of healthy controlsMarcos Pérez-Losada, Eduardo Castro-Nallar, José Laerte Boechat, et al.
Pageof 2